SIGNIFICANCE OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 GENE (SERPINE1: 5G>4G) POLYMORPHISM IN CHORIONIC DETACHMENT AND PLACENTAL ABRUPTION IN EARLY PREGNANCY
- Авторлар: KIRYUSHCHENKOV P.A1, KHODZHAYEVA Z.S1, TETRUASHVILI N.K1, DONNIKOV A.E1, BELOUSOV D.M1, ANDAMOVA E.V1, TAMBOVTSEVA M.A1
-
Мекемелер:
- Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
- Шығарылым: № 5 (2012)
- Беттер: 34-37
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246734
- ID: 246734
Дәйексөз келтіру
Аннотация
Толық мәтін
Авторлар туралы
P. KIRYUSHCHENKOV
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: masha-kirmail@mail.ru
Z. KHODZHAYEVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: zhodjaeva@mail.ru
N. TETRUASHVILI
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: tetruly@mail.ru
A. DONNIKOV
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: donnikov@mdl-lab.ru
D. BELOUSOV
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: slides@narod.ru
E. ANDAMOVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: elena_doctor@mail.ru
M. TAMBOVTSEVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: tambovtsevamr@mail.ru
Әдебиет тізімі
- Герштейн Е.С., Кушлинский Н.Е., Лякина Л.Т. и др. Активаторы плазминогена урокиназного и тканевого типов и их ингибитор (PAI-I) в цитозольной фракции при заболеваниях щитовидной железы // Вестн. РАМН. — 2001. — С. 32—33.
- Кирющенков П.А., Белоусов Д.М., Александрина О.С. Патогенетическое обоснование тактики ведения отслойки хориона и плаценты на ранних сроках беременности // Гинекология. — 2010. — Т. 12, № 1. — С. 36—39.
- Сидельникова В.М., Сухих Г.Т. Невынашивание беременности. — М.: МИА, 2010. — С. 31—43; 380—413.
- Тромбогеморрагические осложнения в акушерско-гинекологической практике / Под ред. А.Д. Макацария. — М.: МИА, 2011. — С. 53—57; 635— 656.
- Feng Q., Liu Y., Liu K. et al. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation // Placenta. — 2000. — Vol. 21. — P. 184—193.
- Iribarren J.L., Jimenez J.J., Hernandez D. et al. Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene // Anesthesiology. — 2008. — Vol. 108, N 4. — P. 596—602.
- Kohler H.P., Grant P.J. Plasminogen-activator inhibitor type 1 and coronary artery disease // N. Engl. J. Med. — 2000. — Vol. 342, № 24. — P. 1792—1801.
- Ma Z., Paek D., Oh C.K. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation // Clin. Exp. Allergy. — 2009. — Vol. 39, № 8. — P. 1136—1144.
- Panahloo A., Mohamed-Ali V., Lane A. et al. Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene // Diabetes. — 1995. — Vol. 44, № 1. — P. 37—42.
- Wiklund P.G., Nilsson L., Ardnor S.N. et al. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts // Stroke. — 2005. — Vol. 36, № 8. — P. 1661—1665.